Epidemiology of Venous Thrombosis and Pulmonary Embolism

Study acronym: LITE
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 11 of 11 entries
  2. 8 versions Re-verified since Oct 10, 2019, no change to tracked fieldsv8-v15
  3. Publications: 8 to 11
    • Study description expanded, about 2 words
    v7
  4. Primary completion date: Apr 2030
    • Study completion date: Dec 2006 to Apr 2030
    • Eligibility criteria expanded, about 13 words
    v6
  5. Re-verified, no change to tracked fieldsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Study description expanded, about 6 wordsv4
  2. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to University of Minnesota
    • Collaborators expanded, about 7 words
    v3
  3. Enrollment target: 21680
    • Study description expanded, about 12 words
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To investigate venous thromboembolism in two carefully conducted prospective epidemiologic studies of African American and white adults -- the Atherosclerosis Risk in Communities (ARIC) Study and the Cardiovascular Health Study (CHS).
Trial Details
NCT Number NCT00005504
Lead Sponsor University of Minnesota
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Cardiovascular Diseases, Pulmonary Embolism, Venous Thrombosis
Related terms Cardiovascular Diseases, Pulmonary Embolism, Venous Thrombosis
Enrollment 21,680 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov